This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Livzon Mabpharm Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Desheng Tao: Innovator in Humanized Antibodies
Introduction
Desheng Tao is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work focuses on improving the safety and efficacy of therapeutic antibodies used in clinical applications.
Latest Patents
Desheng Tao holds a patent for "Humanized anti-TNFα antibodies." This invention provides a humanized anti-TNF monoclonal antibody that significantly reduces the immunogenicity associated with murine antibodies while retaining the ability to recognize antigens. Compared to traditional mouse chimeric antibodies, this innovation enhances the safety of the antibody in clinical applications.
Career Highlights
Desheng Tao is affiliated with Livzon Mabpharm Inc., a company known for its advancements in biopharmaceuticals. His work has been instrumental in the development of therapies that address various medical conditions, showcasing his expertise in the field.
Collaborations
He has collaborated with notable colleagues, including Baoguo Zhu and Bill Nai-Chau Sun, contributing to a dynamic research environment that fosters innovation and development in antibody therapies.
Conclusion
Desheng Tao's contributions to the field of humanized antibodies exemplify the importance of innovation in biotechnology. His work not only enhances therapeutic options but also improves patient safety in clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile